LONG TERM CARE Long Term Care Video Series Osteoporosis Canada, Ontario Osteoporosis Strategy, University of Waterloo and GERAS Centre for Aging Research are excited to announce the launch of four […]

There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]

Recruitment Recruitment Are you a researcher? Osteoporosis Canada will provide support for the recruitment of participants for ethical and reputable research relevant to Osteoporosis Canada’s vision and mission. Interested in […]

An atypical femoral fracture is an uncommon type of hip fracture which has been associated with long term use of certain osteoporosis medications. This type of hip fracture affects the […]

A Fracture Liaison Service (FLS) is a specific model of care where a coordinator pro-actively identifies fracture patients, on a system-wide basis, and determines their fracture risk with the express […]

A development grant to improve osteoporosis care for fragility fracture patients has been awarded to British Columbia’s Fraser Health Authority. Funding for “Breaking The Cycle Of Recurrent Fracture: Scaling Up […]

Latest News A New Clinical Practice Guideline for management of osteoporosis and fracture prevention in Canada October 10, 2023 On October 10, 2023, a new guideline on managing osteoporosis to […]

Support groups, one of the online programs offered by Osteoporosis Canada, are all about connection. They connect people who not only live with osteoporosis but want to live well with […]

If you buy drugs online, you may be putting your health at serious risk. This is especially true if you order prescription drugs without being examined in person by a […]